Truncation of PITX2 differentially affects its activity on physiological targets

Area of Science:

• Molecular Biology
• Genetics
• Endocrinology

Background:

• The bicoid-like transcription factor PITX2 interacts with POU1F1 to regulate prolactin (PRL) and growth hormone (GH) expression in pituitary somatolactotroph cells.
• Axenfeld-Rieger syndrome is associated with mutations in the PITX2 gene, impacting development.

Purpose of the Study:

• To investigate the functional impact of three PITX2 mutants found in Axenfeld-Rieger syndrome patients on the regulation of PRL, GH, and POU1F1 genes.
• To understand how these mutations affect gene activation in both pituitary and non-pituitary cell lines.

Main Methods:

• Utilized reporter gene assays with promoters of human PRL (hPRL), hGH, and POU1F1.
• Transfected these reporter constructs along with wild-type or mutant PITX2 genes into pituitary and non-pituitary cell lines.
• Analyzed the DNA-binding capacity and transcriptional activation potential of PITX2 mutants.

Main Results:

• Two mutants (E101X and F104L) were non-functional or not expressed.
• The PITX2(Y167X) mutant retained DNA-binding ability.
• PITX2(Y167X) significantly enhanced activation of hPRL and POU1F1 promoters but not the hGH promoter.
• This represents the first described PITX2 mutation with differential effects on its target gene promoters.

Conclusions:

• The PITX2(Y167X) mutation exhibits distinct regulatory effects on hPRL and POU1F1 compared to hGH.
• This differential activity may stem from interactions with different transcription factors or cofactors.
• Findings provide a basis for identifying PITX2 protein complexes involved in differential GH and PRL expression.